Dr. Schreck
@Karisa_Schreck
Followers
441
Following
1K
Statuses
190
Translational neuro-oncologist @hopkinskimmel focused on the exploitation of targetable genomic driver mutations in gliomas, particularly BRAF.
Baltimore, MD
Joined June 2016
Great to see this collaborative effort come to fruition! Thank you Lucy Chen, Peng Huang, @last_name_lucas @NeuroOncSurgery @JordinaRT_md, this was a team effort! #Gliosarcoma #GBM @hopkinskimmel
Chen et al @HopkinsNSsurg, @hopkinsneurons, @JHUPath demonstrated Gliosarcoma has a similar overall survival but worse response to treatment and different mutational profile than glioblastoma. #JNO Read More:
0
2
9
Wonderful collaboration with @last_name_lucas and the Neuro-Onc Precision Medicine Group @hopkinskimmel to understand the effect of NF1 loss on sporadic #GBM co-muts and survival. @NeuroOncSurgery @JordinaRT_md @FRodriguezNP @MariaIoannou_MD
1
5
21
Proud to report our group effort with @MKhasraw & the @NeuroOnc #Biospecimen WG promoting multiple biopsies in clinical trials is public in @thelancetOncol. We need to push the envelope on trial design if we are going to change the paradigm for #GBM
2
11
37
Nice work Dr. Bazer! So important to think about dose modification for toxicity and the impact of holding #BRAF targeted therapy for #glioma patients: @hopkinskimmel @NeurosurgUCSF
1
2
14
Exciting to see the @NatureComms real-world report on #CeGaT peptide vaccine in ppl with #GBM. Now for a prospective trial!
0
2
12
@bnamd87 @DOM_UCLA @dgsomucla @MarcoGiovannini @SJNanoTrnsFrmer Congratulations @bnamd87! That’s a great feeling!
0
0
1
I’m extremely excited to announce that on June 26th 2024 we will hold the @KRASKickers @ Johns Hopkins event! We will talk about our efforts to make KRAS mutant cancers curable! Please share and join!
1
0
8
Thank you @NancyAnnBush1 @StephenBagleyMD and Jennie Clark! @NeurosurgUCSF hoping this will draw some attention to the nuances of #BRAF targeted therapy management in #glioma
0
0
4
#NFAwareness month at the @HopkinsMedicine dome tonight and all month! So thankful for the work so many brilliant people are doing here to #cureNF @hopkinskimmel @ntapresearch
0
3
8
@hopkinskimmel @HopkinsMedicine Another huge thanks to the @AACR / @ASCO "Methods in Clinical Cancer Research" course, where I wrote the first draft. It was a tremendous experience.
0
0
0
I just had an insurance company deny #tovorafenib (#Ojemda) for a patient with BRAF-fusion recurrent pilocytic astrocytoma because it wasn't a "pediatric low grade glioma". @PBTC_Research @PBTF @DayOneBio any recommendations/ resources on how to educate insurance companies?
1
1
2
RT @DrAMansouri: Great opportunity at a busy clinical and research program. DM me if interested!
0
3
0
0
0
1
I learned so much from this @ASCO project with @MartinvdenBent and Dr. Mellinghoff @MSKCancerCenter. Thank you @LaurenSchaffMD @GeurtsMarjolei and @MariaIoannou_MD!
0
3
8
0
0
1